Brief: INVO Bioscience Q1 Revenue Rose 165% To $684,500

INVO Fertility

17/05/2021 22:18

May 17 (Reuters) - INVO Bioscience Inc  INVO.O :
    * INVO BIOSCIENCE REPORTS FIRST QUARTER 2021 FINANCIAL AND
OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
    * Q1 REVENUE ROSE 165 PERCENT TO $684,500
    * QTRLY LOSS PER SHARE $0.25
    * AS OF MARCH 31, 2021,  HAD ABOUT $8.4 MILLION IN CASH
COMPARED
TO ABOUT $0.4 MILLION ON MARCH 31, 2020

Source text for Eikon:  ID:nPn5LTWGPa 
Further company coverage:  INVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))